"The year is 2218. Ageing has been cured. Society is not what it used to be..." The first podcast in a new future-facing series sponsored by South African financial services giant Sanlam has just been released, featuring quotes from SRF CSO Dr. Aubrey de Grey.

SRF's founding investment in Antoxerene has led to a landslide of funding for the company. A new $10m joint venture with investment company Juvenescence will now focus on translation of Antoxerene's library of novel senolytic drug candidates.

Check out all the latest news from SENS Research Foundation in our July newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

Prof. Chandan Sen, Chair of Medicine at Ohio State University, discussed his group's ongoing work to directly induce cellular plasticity in the adult body - thus circumventing the technical challenges and limitations of an intermediate stem cell stage.

The Longevity Film Competition has now begun, with entries open until 15th September. To participate create a short film explaining how healthier, longer lives will benefit everyone. As well as potentially helping to save a lot of lives, you could win a first prize of $10,000!

SRF CSO Dr. Aubrey de Grey and Palo Alto Investors president Dr. Joon Yun contributed to a new IEEE career guidance article explaining how engineers will play a crucial role in developing the technology required for healthy longevity.

Following the incredible success of the 2018 event, SRF and Forever Healthy Foundation are delighted to confirm that Undoing Aging 2019 will take place at the Umspannwerk Alexanderplatz in Berlin from March 28-30 (Facebook event). Early bird tickets are now available!

Immusoft founder and CTO Matthew Scholz discussed the company's "ISP" platform technology, which uses a patient's own immune cells to produce therapeutic proteins on a long-term basis - enabling cures for many genetic and age-related diseases.

The Life Extension Advocacy Foundation (LEAF) are hosting a special one-day conference in New York on July 12th. Key researchers, industry experts and investors will meet to discuss how rejuvenation biotechnology can be translated into the clinic.

UCLA human genetics professor Steve Horvath, who developed the "Horvath clock" - a highly accurate molecular biomarker of aging - spoke at Undoing Aging 2018 about the use of epigenetics to measure the benefits of rejuvenation therapies.

The Britain Israel Research and Academic Exchange Partnership (BIRAX) has issued a call for research proposals focused on directly tackling the aging process to prevent age-related disease. We applaud the UK and Israeli governments for their very SENSible approach!

In cooperation with the Forever Healthy Foundation, SRF is inviting candidates to submit research proposals for a three-year Fellowship in Rejuvenation Biotechnology at our Research Center in California. The deadline for initial applications is August 6th 2018.

We're seeking a full-time researcher for a Scientist I position at our Research Center in California, to lead a new intramural research project performing translational research studying aging as it relates to the immune system.